SCHEMBL2929252

SCHEMBL2929252

Cc1ccc(N2CCN(C(=O)OCC3CCCN(C)C3)CC2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.51
GAA P10253 2/20 0.51
LMNA P02545 2/20 0.51
KDM4E B2RXH2 1/20 0.51
CHRNB2 P17787 1/20 0.47
CHRNB4 P30926 1/20 0.47
CHRNA3 P32297 1/20 0.47
CHRNA4 P43681 1/20 0.47
ALDH1A1 P00352 3/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
GPR119 Q8TDV5 1/20 0.46
GFER P55789 1/20 0.45
MAPK1 P28482 1/20 0.44
HTT P42858 1/20 0.44
RAB9A P51151 1/20 0.44
L3MBTL1 Q9Y468 2/20 0.43
AKR1C3 P42330 1/20 0.43
KMT2A Q03164 2/20 0.42
TSHR P16473 1/20 0.42
ATM Q13315 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1183228 1.00 MAPT (0.51) MAPTGAALMNAKDM4ECHRNB2
SCHEMBL1183527 1.00 MAPT (0.51) MAPTGAALMNAKDM4ECHRNB2
SCHEMBL2977994 0.96 MAPT (0.47) MAPTGAALMNAKDM4ECHRNB2
SCHEMBL313986 0.87 MAPT (0.54) MAPTGAALMNAKDM4EALDH1A1
SCHEMBL314918 0.81 MAPT (0.53) MAPTGAALMNAKDM4EALDH1A1
SCHEMBL313990 0.81 MAPT (0.48) MAPTGAALMNAKDM4EALDH1A1
SCHEMBL2977996 0.80 GPR119 (0.40) MAPTGAALMNAKDM4EALDH1A1
SCHEMBL15127501 0.78 MAPT (0.79) MAPTGAALMNAKDM4EALDH1A1
SCHEMBL314622 0.78 CHRM4 (0.57) MAPTGAALMNAKDM4EALDH1A1
SCHEMBL314479 0.78 L3MBTL1 (0.60) MAPTGAALMNAKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2229362-A1 PIPERAZINES AS ANTI-OBESITY AGENTS AstraZeneca AB (SE) 2010-09-22 EP claimed
WO-2009071658-A1 PIPERAZINES AS ANTI-OBESITY AGENTS BIOVITRUM AB (PUBL) (SE) 2009-06-11 WO claimed
EP-2229362-A1 PIPERAZINES AS ANTI-OBESITY AGENTS AstraZeneca AB (SE) 2010-09-22 EP disclosed
WO-2009071658-A1 PIPERAZINES AS ANTI-OBESITY AGENTS BIOVITRUM AB (PUBL) (SE) 2009-06-11 WO disclosed